US equities
|
MU
$1,079.98
▲+3.29%
SNDK
$1,729.63
▲+4.17%
NVDA
$237.05
▼-0.92%
AMD
$643.03
▼-0.98%
SPCX
$168.37
▼-2.06%
INTC
$113.16
▲+0.59%
TSLA
$375.67
▼-1.32%
AAPL
$335.18
▲+0.46%
MU
$1,079.98
▲+3.29%
SNDK
$1,729.63
▲+4.17%
NVDA
$237.05
▼-0.92%
AMD
$643.03
▼-0.98%
SPCX
$168.37
▼-2.06%
INTC
$113.16
▲+0.59%
TSLA
$375.67
▼-1.32%
AAPL
$335.18
▲+0.46%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
OpGen, Inc. - Common Stock
(NQ:
OPGN
)
1.960
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about OpGen, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
ROCE Insights For OpGen
↗
May 24, 2021
During Q1, OpGen's (NASDAQ:OPGN) reported sales totaled $829.72 thousand. Despite a 2.94% in earnings, the company posted a loss of $6.21 million. OpGen collected $1.35 million in...
Via
Benzinga
Recap: OpGen Q1 Earnings
↗
May 13, 2021
Shares of OpGen (NASDAQ:OPGN) moved higher by 1.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 16.28% year over...
Via
Benzinga
Earnings Scheduled For May 13, 2021
↗
May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >